09/18/2024 3:18 PM | Haemonetics (Issuer) Miller Laurie A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/03/2024 3:20 PM | Haemonetics (Issuer) Simon, Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/08/2024 5:04 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 5:05 AM | Haemonetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/30/2024 3:23 PM | Haemonetics (Filer)
| Form 8-K/A | |
07/29/2024 4:03 PM | Haemonetics (Issuer) Strong Stewart W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 3:29 PM | COYLE MICHAEL J (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
07/26/2024 3:30 PM | Bryant Diane M (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 3:32 PM | ABERNATHY ROBERT E (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 3:34 PM | Haemonetics (Issuer) Strong Stewart W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 3:21 PM | Haemonetics (Issuer) Zane Ellen M (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/26/2024 8:47 AM | Haemonetics (Subject) Strong Stewart W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/25/2024 3:10 PM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
07/15/2024 3:27 PM | Haemonetics (Issuer) Lingamneni Anila (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
07/12/2024 3:25 PM | Haemonetics (Subject) Lingamneni Anila (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
07/11/2024 3:42 PM | Haemonetics (Subject) Lingamneni Anila (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/07/2024 5:30 AM | Haemonetics (Filer)
| Form DEFA14A | |
06/07/2024 5:31 AM | Haemonetics (Filer)
| Form ARS | |
06/07/2024 5:26 AM | Haemonetics (Filer)
| Form DEF 14A | |
05/29/2024 4:42 PM | Haemonetics (Issuer) Llorens Josep (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:44 PM | Haemonetics (Issuer) Lingamneni Anila (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:27 PM | Haemonetics (Issuer) Strong Stewart W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:31 PM | Haemonetics (Issuer) Simon, Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:35 PM | Haemonetics (Issuer) Miller Laurie A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 4:38 PM | Basil Michelle L (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/29/2024 3:06 PM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/29/2024 10:06 AM | Basil Michelle L (Reporting) Haemonetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/29/2024 9:24 AM | Haemonetics (Subject) Strong Stewart W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/23/2024 5:03 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/21/2024 4:49 PM | Galvin Roy (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:52 PM | Haemonetics (Issuer) Llorens Josep (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:55 PM | Haemonetics (Issuer) Lingamneni Anila (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:58 PM | Haemonetics (Issuer) Miller Laurie A. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 5:01 PM | Haemonetics (Issuer) Strong Stewart W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 5:05 PM | Haemonetics (Issuer) Maunsell Farris Maryanne (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:41 PM | DArecca James (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:46 PM | Basil Michelle L (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/21/2024 4:38 PM | Haemonetics (Issuer) Simon, Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/20/2024 10:13 AM | Basil Michelle L (Reporting) Haemonetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 10:24 AM | Haemonetics (Subject) Strong Stewart W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/20/2024 9:45 AM | Haemonetics (Subject) Llorens Josep (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
[Urgent] Starlink Set For The Largest IPO In History? (Ad) He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant.
Then, he did it again with Tesla… which is up more than 19,500% since 2010.
For perspective, that turns $100 invested into almost $20,000!
And now, Elon could be set to do it for the third and final time… with what might be his biggest breakthrough yet.
And for the first time ever, you have the rare chance to profit BEFORE the upcoming IPO. Click here now for the urgent details on this hidden play. |
05/20/2024 5:16 AM | Haemonetics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
05/17/2024 4:11 PM | Haemonetics (Issuer) Strong Stewart W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 3:52 PM | DArecca James (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 3:55 PM | Haemonetics (Issuer) Llorens Josep (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/17/2024 11:15 AM | Basil Michelle L (Reporting) Haemonetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/17/2024 9:07 AM | Haemonetics (Subject) Llorens Josep (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 11:57 AM | Haemonetics (Subject) Llorens Josep (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 11:12 AM | Basil Michelle L (Reporting) Haemonetics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/16/2024 11:15 AM | Haemonetics (Subject) Strong Stewart W (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
05/09/2024 5:04 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 3:21 PM | Haemonetics (Issuer) Lingamneni Anila (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/06/2024 1:08 PM | Haemonetics (Subject) Lingamneni Anila (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
04/17/2024 3:18 PM | Haemonetics (Issuer) Lingamneni Anila (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/01/2024 7:01 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/13/2024 3:44 PM | Haemonetics (Issuer) Simon, Christopher (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
03/05/2024 5:10 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 2:28 PM | Haemonetics (Subject) Neuberger Berman Group LLC (Filed by)
| Form SC 13G/A | |
02/09/2024 4:49 PM | Capital Research Global Investors (Filed by) Haemonetics (Subject)
| Form SC 13G/A | |
02/08/2024 9:21 AM | Haemonetics (Subject) WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
02/08/2024 5:05 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/08/2024 5:06 AM | Haemonetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
12/12/2023 5:09 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/03/2023 3:36 PM | Galvin Roy (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/02/2023 5:19 AM | Haemonetics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/02/2023 5:16 AM | Haemonetics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/24/2023 3:23 PM | Haemonetics (Issuer) Strong Stewart W (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/24/2023 3:27 PM | Basil Michelle L (Reporting) Haemonetics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |